Runben Biotechnology (603193)

Search documents
润本股份(603193) - 2024年度募集资金存放与实际使用情况的专项报告
2025-04-24 12:54
证券代码:603193 证券简称:润本股份 公告编号:2025-010 润本生物技术股份有限公司 2024年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集 资金管理和使用的监管要求》《上海证券交易所上市公司自律监管指引第1号— —规范运作》《上海证券交易所股票上市规则》等相关规定,现将润本生物技 术股份有限公司(以下简称"公司")2024年度的募集资金存放与实际使用情 况报告如下: 一、募集资金基本情况 (一)实际募集资金金额和资金到位时间 经中国证券监督管理委员会(以下简称"中国证监会")出具的《关于同 意润本生物技术股份有限公司首次公开发行股票注册的批复》(证监许可 [2023]1631号)核准,公司于2023年9月27日首次公开发行人民币普通股(A股) 60,690,000股,发行价格为人民币17.38元/股,募集资金总额为人民币105,479.22 万元(人民币,下同),扣除不含税的发行费用8,356.37万元, ...
润本股份(603193) - 董事、监事、高级管理人员2024年度薪酬发放情况及2025年度薪酬方案的公告
2025-04-24 12:54
证券代码:603193 证券简称:润本股份 公告编号:2025-011 润本生物技术股份有限公司 (一)适用对象 公司 2025 年度任期内的董事、监事和高级管理人员。 (二)适用期限 2025 年 1 月 1 日至 2025 年 12 月 31 日。 (三)公司董事 2025 年度薪酬方案 1、公司非独立董事按其在公司担任的具体岗位、行政职务,以及在实际工 作中的履职能力和工作绩效领取薪酬,不领取董事津贴。 董事、监事、高级管理人员 2024 年度薪酬发放情况 及 2025 年度薪酬方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 润本生物技术股份有限公司(以下简称"公司")于 2025 年 4 月 11 日召 开第二届董事会薪酬委员会第二次会议,审议通过了《关于公司董事、高级管 理人员 2024 年度薪酬发放情况及 2025 年度薪酬方案的议案》;于 2025 年 4 月 24 日召开第二届董事会第七次会议和第二届监事会第五次会议,分别审议通过 了《关于公司董事、高级管理人员 2024 年度薪酬发放情况及 202 ...
润本股份:2024年报净利润3亿 同比增长32.74%
Tong Hua Shun Cai Bao· 2025-04-24 09:41
一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.7400 | 0.6400 | 15.63 | 0.4700 | | 每股净资产(元) | 5.14 | 4.75 | 8.21 | 2.1 | | 每股公积金(元) | 2.51 | 2.51 | 0 | 0.3 | | 每股未分配利润(元) | 1.47 | 1.12 | 31.25 | 0.70 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 13.18 | 10.33 | 27.59 | 8.56 | | 净利润(亿元) | 3 | 2.26 | 32.74 | 1.6 | | 净资产收益率(%) | 14.91 | 22.64 | -34.14 | 24.92 | 数据四舍五入,查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有: 4098.8万股,累计占流通股比: 39.66%,较上期变化: 288 ...
润本股份:2025年一季度净利润4419.74万元,同比增长24.60%
news flash· 2025-04-24 09:34
润本股份(603193)公告,2025年第一季度营收为2.4亿元,同比增长44.00%;净利润为4419.74万元, 同比增长24.60%。 ...
趋势研判!2025年中国国潮行业产业链图谱、市场规模、竞争格局及未来前景分析:“国潮”风盛行,产业经济加速发展[图]
Chan Ye Xin Xi Wang· 2025-04-18 01:17
Industry Overview - The "Guochao" movement refers to products that integrate traditional Chinese culture with modern aesthetics and fashion elements, gaining popularity among consumers as their cultural confidence increases [1][5] - The Guochao industry is becoming a significant growth driver in China's economy, particularly in the new consumption sector, with a market size projected to grow from 12,266.6 billion yuan in 2018 to 22,922.3 billion yuan in 2024 [1][9] Industry Chain - The upstream of the Guochao industry includes cultural resources and raw material supply chain integration, focusing on intangible cultural heritage and traditional aesthetics [3] - The midstream consists of innovative operations of Guochao brands, with notable brands including Li Ning, Anta, and Huawei [3] - The downstream involves sales and consumption of Guochao products through various online platforms and retail stores [3] Current Industry Status - Recent government policies emphasize the importance of cultural confidence and the promotion of traditional Chinese culture, supporting the development of the Guochao economy [5][7] - Various measures have been introduced to foster new consumption brands and promote Guochao products, including fashion items that reflect Chinese aesthetics [5][7] Market Trends - Consumer interest in Guochao products is driven by their fashion appeal and unique cultural connotations, particularly among the Z generation and millennials [9] - The Guochao economy is expected to exceed 30,000 billion yuan by 2028, indicating a robust growth trajectory [9] Competitive Landscape - The Guochao market features a diverse range of participants, including traditional brands, new local brands, and tech giants, creating a "three-legged" competitive structure [11] - Leading brands like Li Ning and Anta are revitalizing their image to capture the sports fashion market, while new brands leverage cultural aesthetics to reshape the beauty market [11] Development Trends - The Guochao theme is gaining traction, with over 80% of consumers expressing confidence in the industry's future [18] - Local brands are encouraged to focus on product quality and innovation to transition from manufacturing to brand development [19] - As brands expand into overseas markets, localization strategies will be crucial for success [20]
润本股份(603193) - 简式权益变动报告书
2025-04-16 09:03
润本生物技术股份有限公司 简式权益变动报告书 上市公司名称:润本生物技术股份有限公司 股票上市地点:上海证券交易所 股票简称:润本股份 名称:JNRY VIII HK Holdings Limited 住所:Unit 1402, 14th Floor, Henley Building, No.5 Queen's Road Central, Hong Kong 通讯地址:Unit 1402, 14th Floor, Henley Building, No.5 Queen's Road Central, Hong Kong 股份变动性质:股份减少(减持) 签署日期:2025年4月15日 1 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》《上市公司收购管理办法》《 公开发行证券的公司信息披露内容与格式准则第15号——权益变动报告书(2025年修 订)》等法律法规及规范性文件编写本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准,其实施亦不违反信 息披露义务人公司章程或内部规则中的任何条款,或与之相冲突。 股票代码:603193 信息披露义务人: | 第一节 | 释义 | 4 | | ...
润本股份:JNRY VIII持股比例降至5%
news flash· 2025-04-16 08:42
Core Viewpoint - JNRY VIII, a non-controlling shareholder holding over 5% of the shares, has reduced its stake in Runben Co., Ltd. (603193) due to fund investment operations, decreasing its shareholding from 34.39 million shares to 20.22 million shares, which represents a reduction in ownership from 8.50% to 5.00% [1] Summary by Relevant Categories - **Shareholding Changes** - JNRY VIII's shareholding decreased by 3.50% [1] - The number of shares held by JNRY VIII dropped from 34.39 million to 20.22 million [1] - The previous ownership percentage was 8.50%, which has now changed to 5.00% [1]
商贸零售行业周报:关税冲击持续,关注内需优质渠道和产品龙头-20250413
KAIYUAN SECURITIES· 2025-04-13 11:11
Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report emphasizes the ongoing impact of tariff shocks and suggests focusing on high-quality retail channels and differentiated consumer brands that cater to domestic demand [4][22] - The report highlights the transformation of traditional retail, with Yonghui Supermarket leading the way in adapting to a consumer-centric retail era [4][22] - The rise of domestic brands and the recovery of consumer demand are seen as inevitable trends, with recommendations to focus on quality retail channels and differentiated brands [4][22] Summary by Sections Retail Market Review - The retail industry index rose by 2.88% during the week of April 7 to April 11, outperforming the Shanghai Composite Index, which fell by 3.11% [6][13] - The supermarket sector showed the largest increase, with a weekly rise of 13.54% [14][17] - Notable individual stock performances included Guofang Group (+61.1%), Eurasia Group (+26.3%), and Nanning Department Store (+22.4%) [19][20] Industry Dynamics - Yonghui Supermarket has opened a "green channel" for domestic manufacturers affected by export restrictions, receiving over 100 cooperation requests from various sectors [4][22] - The report discusses the approval of a new collagen product by Jinbo Bio, which is expected to strengthen its leading position in the medical beauty sector [4][23] Investment Recommendations - Investment focus areas include: - Traditional retail: Highlighting companies like Yonghui Supermarket and Aiyingshi that are adapting to consumer trends [7][27] - Gold and jewelry: Recommendations for brands like Laopu Gold and Chaohongji that possess differentiated product capabilities [7][28] - Cosmetics: Emphasizing domestic brands such as Maogeping and Shangmei that are expanding into high-potential segments [7][28] - Medical aesthetics: Focusing on companies like Aimeike and Kedi that are positioned to benefit from the recovery in medical beauty consumption [7][28] Company-Specific Insights - Laopu Gold reported a revenue of 8.506 billion yuan (+167.5%) and a net profit of 1.473 billion yuan (+253.9%) for FY2024, indicating strong growth potential [29] - Yonghui Supermarket's revenue for the first three quarters of 2024 was 54.549 billion yuan (-12.1%), with a net loss of 78 million yuan, but it is undergoing significant transformation [32] - Jinbo Bio's new collagen product is expected to provide both immediate filling effects and stimulate collagen regeneration, enhancing its competitive edge in the market [23][24]
润本股份:夏季旺季将至,新品值得期待
Xinda Securities· 2025-04-02 14:23
证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 润本股份(603193) 投资评级 上次评级 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号:S1500524120004 邮 箱: jiangwenqiang@cindasc.com [Table_Title] 润本股份:夏季旺季将至,新品值得期待 [Table_ReportDate] 2025 年 04 月 02 日 [Table_S 事件:线下方面,渠道稳步扩张、盈利水平较优, ummary] 25 年可倒喷驱蚊液、童 锁款电热蚊香液已进驻山姆渠道;线上方面,根据蝉妈妈,25 年 3 月抖音 GMV 同比+35.4%、Q1 同比+67.3%;根据久谦,25 年 1-2 月三平台(天 猫+京东+抖音)合计 GMV 同比+55.2%,其中天猫/京东分别同比 +41.9%/+25.1%,延续靓丽增长。 核心逻辑:公司通过驱蚊-婴童-青少年,已逐步积累较大的用户群体基数; 且依拓产研销一体化,差异化质价比营销,消费者口碑优异,建立用户资产 沉淀,后续持续拓展品类有望实现持续 ...
润本股份(603193):夏季旺季将至,新品值得期待
Xinda Securities· 2025-04-02 13:01
Investment Rating - The investment rating for Runben Co., Ltd. (603193) is not explicitly stated in the provided documents, but the report indicates a positive outlook on the company's performance and growth potential [1]. Core Views - The company is expected to benefit from the upcoming summer season with new product launches, including mosquito repellent and skincare products targeted at children and teenagers [1][2]. - The company has established a significant user base through its product lines focused on mosquito repellent, children's products, and youth skincare, which is anticipated to drive sustained high growth [2]. - The sales performance of new products, such as the sunscreen gel launched in February and the upcoming youth skincare line, is expected to contribute positively to revenue growth [2]. Financial Summary - The total revenue for Runben Co., Ltd. is projected to grow from 1,033 million in 2023 to 2,178 million in 2026, reflecting a compound annual growth rate (CAGR) of approximately 27% [3]. - The net profit attributable to the parent company is expected to increase from 226 million in 2023 to 518 million in 2026, with growth rates of 41.2% in 2023 and 28.7% in 2026 [3]. - The gross profit margin is forecasted to improve from 56.3% in 2023 to 59.3% in 2026, indicating enhanced profitability [3]. - The price-to-earnings (P/E) ratio is projected to decrease from 62.87 in 2023 to 27.46 in 2026, suggesting a more attractive valuation over time [3].